FLAT Prices Act

United States116th CongressHR-1188House of Representatives
Updated: Feb 14, 2019

Summary

Forcing Limits on Abusive and Tumultuous Prices or the FLAT Prices Act This bill directs the Food and Drug Administration to reduce the market exclusivity of an approved prescription drug if the drug manufacturer increases the drug's price by more than a specified percentage. This reduction may be waived under specified circumstances.

Bill texts

Available versions
Introduced (House)View official text

1 version available

All available records shown.

Timeline

Latest companion bill action

S-366: FLAT Prices Act

Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S921-922)

  1. Introduced in House

  2. Referred to the House Committee on Energy and Commerce.

    House of Representatives

  3. Referred to the Subcommittee on Health.

    House of Representatives

All available records shown.